Kamilė Stankevičiūtė
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kamilė Stankevičiūtė has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Ethan Steinberg
Center for Biomedical Informatics Research, Stanford University, Stanford, CA, USA
2 shared publications - Hyewon Jeong
Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, USA
2 shared publications - Justin Xu
Big Data Institute, University of Oxford, Oxford, UK
2 shared publications - Matthew B. A. McDermott
Department of Biomedical Informatics, Columbia University, New York, NY, USA
2 shared publications - Michael Wornow
Department of Computer Science, Stanford University, Stanford, CA, USA
2 shared publications - Nassim Oufattole
Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, USA
2 shared publications
Latest Publications
- 28 May 2026
- Published by Massachusetts Medical Society in NEJM AI
- Vol. 3 (6)
MEDS — An Emerging Data Standard and Ecosystem for Health AI Research
- 28 May 2026
- Published by Massachusetts Medical Society in NEJM AI
- Vol. 3 (6)
MEDS — An Emerging Data Standard and Ecosystem for Health AI Research
- Open Access
- 3 August 2025
- Published by Association for Computing Machinery (ACM)
- p. 6243-6244
MEDS: Building Models and Tools in a Reproducible Health AI Ecosystem
- 3 August 2025
- Published by Association for Computing Machinery (ACM)
- p. 6243-6244
Open AccessMEDS: Building Models and Tools in a Reproducible Health AI Ecosystem
- 6 October 2023
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 62 (11) , 1551-1565
Bridging the Worlds of Pharmacometrics and Machine Learning
Precision medicine requires individualized modeling of disease and drug dynamics, with machine learning-based computational techniques gaining increasing popularity. The complexity of either field, however, makes current pharmacological problems opaque to machine learning practitioners, and state-of-the-art machine learning methods inaccessible to pharmacometricians. To help bridge the two worlds, we provide an introduction to current problems and techniques in pharmacometrics that ranges from pharmacokinetic and pharmacodynamic modeling to pharmacometric simulations, model-informed precision dosing, and systems pharmacology, and review some of the machine learning approaches to address them. We hope this would facilitate collaboration between experts, with complementary strengths of principled pharmacometric modeling and flexibility of machine learning leading to synergistic effects in pharmacological applications.
- 6 October 2023
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 62 (11) , 1551-1565
Bridging the Worlds of Pharmacometrics and Machine Learning
Precision medicine requires individualized modeling of disease and drug dynamics, with machine learning-based computational techniques gaining increasing popularity. The complexity of either field, however, makes current pharmacological problems opaque to machine learning practitioners, and state-of-the-art machine learning methods inaccessible to pharmacometricians. To help bridge the two worlds, we provide an introduction to current problems and techniques in pharmacometrics that ranges from pharmacokinetic and pharmacodynamic modeling to pharmacometric simulations, model-informed precision dosing, and systems pharmacology, and review some of the machine learning approaches to address them. We hope this would facilitate collaboration between experts, with complementary strengths of principled pharmacometric modeling and flexibility of machine learning leading to synergistic effects in pharmacological applications.
- Open Access
Population Graph GNNs for Brain Age Prediction
Many common neurological and neurodegenerative disorders, such as Alzheimer’s disease, dementia and multiple sclerosis, have been associated with abnormal patterns of apparent ageing of the brain. Discrepancies between the estimated brain age and the actual chronological age (brain age gaps) can be used to understand the biological pathways behind the ageing process, assess an individual’s risk for various brain disorders and identify new personalised treatment strategies. By flexibly integrating minimally preprocessed neuroimaging and non-imaging modalities into a population graph data structure, we train two types of graph neural network (GNN) architectures to predict brain age in a clinically relevant fashion as well as investigate their robustness to noisy inputs and graph sparsity. The multimodal population graph approach has the potential to learn from the entire cohort of healthy and affected subjects of both sexes at once, capturing a wide range of confounding effects and detecting variations in brain age trends between different sub-populations of subjects.
Open AccessPopulation Graph GNNs for Brain Age Prediction
Many common neurological and neurodegenerative disorders, such as Alzheimer’s disease, dementia and multiple sclerosis, have been associated with abnormal patterns of apparent ageing of the brain. Discrepancies between the estimated brain age and the actual chronological age (brain age gaps) can be used to understand the biological pathways behind the ageing process, assess an individual’s risk for various brain disorders and identify new personalised treatment strategies. By flexibly integrating minimally preprocessed neuroimaging and non-imaging modalities into a population graph data structure, we train two types of graph neural network (GNN) architectures to predict brain age in a clinically relevant fashion as well as investigate their robustness to noisy inputs and graph sparsity. The multimodal population graph approach has the potential to learn from the entire cohort of healthy and affected subjects of both sexes at once, capturing a wide range of confounding effects and detecting variations in brain age trends between different sub-populations of subjects.